Is there hope for digital health startups post-Roe?

Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.

This is our Wednesday show, where we niche down to a single topic, think about a question and unpack the rest. This week, Natasha asked: How do digital health startups build in a post-Roe world?

The question comes after Natasha’s recent Startups Weekly column, “When your startup’s core mission is set to be overturned.” The piece explores the ripple effects of the looming Roe v. Wade overturn, specifically in how it impacts startups. But let’s not hypothesize. We brought on Kiki Freedman, the CEO and co-founder of Hey Jane, to answer our big questions about building, raising and existing when so much regulatory scrutiny is weighing on your business. A direct-to-consumer health company that specializes in the delivery of abortion pills, Hey Jane is about to kick off its fundraising process, which makes for an interesting tension. The startup — especially today — really sits in the middle of two intense moments: an overturn to Roe v. Wade would threaten all of its work, and a toughening, risk-averse VC market could be a hurdle toward next financing.

Enjoy the show, and let us know if you like this interview format. Also, here’s the Found interview that we referenced during the show!

Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts.